
Pisa 4000mg/500mg Injection
Marketer
Venus Remedies Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Pisa 4000mg/500mg Injection
Combiflox 4000 mg/500 mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, its dosage and frequency are determined by a physician based on the patient's condition. Strict adherence to the prescribed regimen is crucial. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues; dosage adjustments or alternative medications may be necessary. Under medical guidance, this injection is generally deemed safe during pregnancy and lactation.
Uses of Pisa 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Pisa 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Pisa 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pisa 4000mg/500mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Pisa 4000mg/500mg Injection works:
Pisa Injection (4000 mg/500 mg) combines piperacillin, an antibiotic that disrupts bacterial cell wall synthesis, with tazobactam, a beta-lactamase inhibitor. This combination strengthens piperacillin's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Pisa 4000 mg/500 mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Pisa (4000 mg/500 mg) is typically deemed safe for use throughout gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Pisa (4000 mg/500 mg) presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no discernible threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pisa 4000 mg/500 mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administering Pisa 4000 mg/500 mg Injection requires careful consideration. A modified dosage of Pisa 4000 mg/500 mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pisa 4000 mg/500 mg Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Pisa 4000mg/500mg Injection :
Omit a Pisa 4000 mg/500 mg Injection dose? Seek your physician's advice.
Facts to Know About Pisa 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
